Immunosuppression in the treatment of glomerulonephritis.
D003520:Cyclophosphamide / Q000627:therapeutic use; D004341:Drug Evaluation; D005921:Glomerulonephritis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000188:drug therapy; D012107:Research Design
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide